Blue Door is the first treatment center in the world to combine the use of cannabis with traditional medicine as an exit strategy for opiate use disorder.
To understand why cannabis is a game changer for opiate dependence treatment, we must explore the neuropharmacology. The opiate and cannabis receptors are expressed in the same areas of the brain. However, cannabis doesn’t affect breathing, the cause of opiate overdose deaths. For this reason, Blue Door utilizes cannabis as a solution for withdrawal symptoms, and research shows that some cannabinoids can even help with cravings. It’s been proven that thousands of fewer patients die from an overdose when cannabis is an option in their treatment plan.
Using cannabis to treat opiate withdrawal is not substituting one drug for another. To the contrary, our physicians successfully use cannabis as an exit strategy to treat opiate dependence. If during the initial consultation medical cannabis is identified as a potential treatment, Blue Door will assist the patient in receiving their medical marijuana card and provide a list of recommended dispensaries. Cannabis is not the right answer for all patients, but it shows incredible promise as a key option in treatment plans.
Our policy regarding cannabis use is:
- All patients must be certified for treatment by our trusted physicians .
- We must be able to show a benefit of cannabis use through documentation of either acceptable withdrawal symptom treatment or a decrease in the amount of opiates the patient needs to use. If using cannabis does not achieve either of these two goals then its use must be critically assessed.
- Medical cannabis must be either obtained from a state-licensed dispensary or grown legally by the patient or his/her caregiver.